Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation

Journal of Immunology

Volumn 192, Issue 3, 2014, Pages 1130-1137

  Morimoto, Kazushi ^a,b   Shirata, Naritoshi ^a   Taketomi, Yoshitaka ^c,d   Tsuchiya, Soken ^b,d   Segi Nishida, Eri ^a   Inazumi, Tomoaki ^a,b,d   Kabashima, Kenji ^a   Tanaka, Satoshi ^e   Murakami, Makoto ^c,d   Narumiya, Shuh ^a   Sugimoto, Yukihiko ^a,b,d  

^a KYOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CALCIUM ION; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTIDINE DECARBOXYLASE; MYELOPEROXIDASE; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EDEMA; ENZYME ACTIVITY; HISTAMINE RELEASE; INFLAMMATION; LEUKOCYTE FUNCTION; MAST CELL; MAST CELL DEGRANULATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SWELLING;

ANIMALS; ARACHIDONIC ACID; CALCIUM; CAPILLARY PERMEABILITY; CELL DEGRANULATION; DINOPROSTONE; EDEMA; HISTAMINE RELEASE; INFLAMMATION; INTERLEUKIN-6; MAST CELLS; MICE; MICE, INBRED C57BL; NEUTROPHIL ACTIVATION; PEROXIDASE; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 84893355942     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300290     Document Type: Article

References (52)

1. Perretti, M., and A. Ahluwalia. 2000. The microcirculation and inflammation: site of action for glucocorticoids. Microcirculation 7: 147-161.
2. Kawai, T., and S. Akira. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-650.
3. Meyer, T., E. Stockfleth, and E. Christophers. 2007. Immune response profiles in human skin. Br. J. Dermatol. 157(Suppl. 2): 1-7.
4. Stables, M. J., and D.W. Gilroy. 2011. Old and new generation lipid mediators in acute inflammation and resolution. Prog. Lipid Res. 50: 35-51.
5. Moncada, S., S. H. Ferreira, and J. R. Vane. 1973. Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature 246: 217-219.
6. Williams, T. J., and J. Morley. 1973. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 246: 215-217.
7. Hata, A. N., and R. M. Breyer. 2004. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Ther. 103: 147-166.
8. Narumiya, S., Y. Sugimoto, and F. Ushikubi. 1999. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79: 1193-1226.
9. Sugimoto, Y., and S. Narumiya. 2007. Prostaglandin E receptors. J. Biol. Chem. 282: 11613-11617.
10. Goulet, J. L., A. J. Pace, M. L. Key, R. S. Byrum, M. Nguyen, S. L. Tilley, S. G. Morham, R. Langenbach, J. L. Stock, J. D. McNeish, et al. 2004. Eprostanoid-3 receptors mediate the proinflammatory actions of prostaglandin E2 in acute cutaneous inflammation. J. Immunol. 173: 1321-1326.
11. Lewis, A. J., D. J. Nelson, and M. F. Sugrue. 1975. On the ability of prostaglandin E1, and arachidonic acid to modulate experimentally induced oedema in the rat paw. Br. J. Pharmacol. 55: 51-56.
12. Marshall, J. S. 2004. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4: 787-799.
13. Galli, S. J., and M. Tsai. 2010. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur. J. Immunol. 40: 1843-1851.
14. Gomi, K., F. G. Zhu, and J. S. Marshall. 2000. Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism. J. Immunol. 165: 6545-6552.
15. Wang, X. S., and H. Y. Lau. 2006. Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors. Allergy 61: 503-506.
16. Chan, C. L., R. L. Jones, and H. Y. Lau. 2000. Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-Activated rat peritoneal mast cells. Br. J. Pharmacol. 129: 589-597.
17. Kay, L. J., W. W. Yeo, and P. T. Peachell. 2006. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation. Br. J. Pharmacol. 147: 707-713.
18. Matsuda, H., K. Kawakita, Y. Kiso, T. Nakano, and Y. Kitamura. 1989. Substance P induces granulocyte infiltration through degranulation of mast cells. J. Immunol. 142: 927-931.
19. Dudeck, A., J. Dudeck, J. Scholten, A. Petzold, S. Surianarayanan, A. Kohler, K. Peschke, D. Vohringer, C. Waskow, T. Krieg, et al. 2011. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 34: 973-984.
20. Kaplan, D. H., B. Z. Igyártó, and A. A. Gaspari. 2012. Early immune events in the induction of allergic contact dermatitis. Nat. Rev. Immunol. 12: 114-124.
21. Martin, S. F., J. C. Dudda, E. Bachtanian, A. Lembo, S. Liller, C. Du rr, M. M. Heimesaat, S. Bereswill, G. Fejer, R. Vassileva, et al. 2008. Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J. Exp. Med. 205: 2151-2162.
22. Ikegami, R., Y. Sugimoto, E. Segi, M. Katsuyama, H. Karahashi, F. Amano, T. Maruyama, H. Yamane, S. Tsuchiya, and A. Ichikawa. 2001. The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages. J. Immunol. 166: 4689-4696.
23. Under Kitamura, Y., H. Matsuda, and K. Hatanaka. 1979. Clonal nature of mast-cell clusters formed in W/Wv mice after bone marrow transplantation. Nature 281: 154-155.
24. Grimbaldeston, M. A., C. C. Chen, A. M. Piliponsky, M. Tsai, S. Y. Tam, and S. J. Galli. 2005. Mast cell-deficient W-sash c-kit mutant KitW-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167: 835-848.
25. Ohtsu, H., S. Tanaka, T. Terui, Y. Hori, Y. Makabe-Kobayashi, G. Pejler, E. Tchougounova, L. Hellman, M. Gertsenstein, N. Hirasawa, et al. 2001. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett. 502: 53-56.
26. Ushikubi, F., E. Segi, Y. Sugimoto, T. Murata, T. Matsuoka, T. Kobayashi, H. Hizaki, K. Tuboi, M. Katsuyama, A. Ichikawa, et al. 1998. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 395: 281-284.
27. Hizaki, H., E. Segi, Y. Sugimoto, M. Hirose, T. Saji, F. Ushikubi, T. Matsuoka, Y. Noda, T. Tanaka, N. Yoshida, et al. 1999. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP2. Proc. Natl. Acad. Sci. USA 96: 10501-10506.
28. Segi, E., Y. Sugimoto, A. Yamasaki, Y. Aze, H. Oida, T. Nishimura, T. Murata, T. Matsuoka, F. Ushikubi, M. Hirose, et al. 1998. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem. Biophys. Res. Commun. 246: 7-12.
29. Kabashima, K., T. Saji, T. Murata, M. Nagamachi, T. Matsuoka, E. Segi, K. Tsuboi, Y. Sugimoto, T. Kobayashi, Y. Miyachi, et al. 2002. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest. 109: 883-893.
30. Kabashima, K., D. Sakata, M. Nagamachi, Y. Miyachi, K. Inaba, and S. Narumiya. 2003. Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9: 744-749.
31. Yao, C., D. Sakata, Y. Esaki, Y. Li, T. Matsuoka, K. Kuroiwa, Y. Sugimoto, and S. Narumiya. 2009. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat. Med. 15: 633-640.
32. Suzawa, T., C. Miyaura, M. Inada, T. Maruyama, Y. Sugimoto, F. Ushikubi, A. Ichikawa, S. Narumiya, and T. Suda. 2000. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 141: 1554-1559.
33. Bradley, P. P., D. A. Priebat, R. D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78: 206-209.
34. Shore, P. A., A. Burkhalter, and V. H. Cohn, Jr. 1959. A method for the fluorometric assay of histamine in tissues. J. Pharmacol. Exp. Ther. 127: 182-186.
35. Tanaka, S., Y. Takasu, S. Mikura, N. Satoh, and A. Ichikawa. 2002. Antigenindependent induction of histamine synthesis by immunoglobulin E in mouse bone marrow-derived mast cells. J. Exp. Med. 196: 229-235.
36. Tanaka, S., S. Mikura, E. Hashimoto, Y. Sugimoto, and A. Ichikawa. 2005. Ca2+ influx-mediated histamine synthesis and IL-6 release in mast cells activated by monomeric IgE. Eur. J. Immunol. 35: 460-468.
37. Rao, T. S., J. L. Currie, A. F. Shaffer, and P. C. Isakson. 1993. Comparative evaluation of arachidonic acid (AA)-And tetradecanoylphorbol acetate (TPA)-induced dermal inflammation. Inflammation 17: 723-741.
38. Sakanaka, M., S. Tanaka, Y. Sugimoto, and A. Ichikawa. 2008. Essential role of EP3 subtype in prostaglandin E2-induced adhesion of mouse cultured and peritoneal mast cells to the Arg-Gly-Asp-enriched matrix. Am. J. Physiol. Cell Physiol. 295: C1427-C1433.
39. Schwelberger, H. G., A. Hittmair, and S. D. Kohlwein. 1998. Analysis of tissue and subcellular localization of mammalian diamine oxidase by confocal laser scanning fluorescence microscopy. Inflamm. Res. 47(Suppl. 1): S60-S61.
40. Negishi, M., Y. Sugimoto, Y. Hayashi, T. Namba, A. Honda, A. Watabe, S. Narumiya, and A. Ichikawa. 1993. Functional interaction of prostaglandin E receptor EP3 subtype with guanine nucleotide-binding proteins, showing lowaffinity ligand binding. Biochim. Biophys. Acta 1175: 343-350.
41. Sudo, N., K. Tanaka, Y. Koga, Y. Okumura, C. Kubo, and K. Nomoto. 1996. Extracellular ATP activates mast cells via a mechanism that is different from the activation induced by the cross-linking of Fc receptors. J. Immunol. 156: 3970-3979.
42. Stokes, A. J., L. M. Shimoda, M. Koblan-Huberson, C. N. Adra, and H. Turner. 2004. A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells. J. Exp. Med. 200: 137-147.
43. Hashimoto, T., H. Ohata, K. Momose, and K. Honda. 2005. Lysophosphatidic acid induces histamine release from mast cells and skin fragments. Pharmacology 75: 13-20.
44. Baba, Y., K. Nishida, Y. Fujii, T. Hirano, M. Hikida, and T. Kurosaki. 2008. Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses. Nat. Immunol. 9: 81-88.
45. Nishida, K., S. Yamasaki, Y. Ito, K. Kabu, K. Hattori, T. Tezuka, H. Nishizumi, D. Kitamura, R. Goitsuka, R. S. Geha, et al. 2005. FcεRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane. J. Cell Biol. 170: 115-126.
46. Kuehn, H. S., M. Radinger, J. M. Brown, K. Ali, B. Vanhaesebroeck, M. A. Beaven, D. D. Metcalfe, and A. M. Gilfillan. 2010. Btk-dependent Rac activation and actin rearrangement following FcεRI aggregation promotes enhanced chemotactic responses of mast cells. J. Cell Sci. 123: 2576-2585.
47. Nishida, K., S. Yamasaki, A. Hasegawa, A. Iwamatsu, H. Koseki, and T. Hirano. 2011. Gab2, via PI-3K, regulates ARF1 in FcεRI-mediated granule translocation and mast cell degranulation. J. Immunol. 187: 932-941.
48. Kabashima, K., M. Nagamachi, T. Honda, C. Nishigori, Y. Miyachi, Y. Tokura, and S. Narumiya. 2007. Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors. Lab. Invest. 87: 49-55.
49. McLoughlin, R. M., S. M. Hurst, M. A. Nowell, D. A. Harris, S. Horiuchi, L. W. Morgan, T. S. Wilkinson, N. Yamamoto, N. Topley, and S. A. Jones. 2004. Differential regulation of neutrophil-Activating chemokines by IL-6 and its soluble receptor isoforms. J. Immunol. 172: 5676-5683.
50. Watson, C., S. Whittaker, N. Smith, A. J. Vora, D. C. Dumonde, and K. A. Brown. 1996. IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin. Exp. Immunol. 105: 112-119.
51. Hatae, N., A. Kita, S. Tanaka, Y. Sugimoto, and A. Ichikawa. 2003. Induction of adherent activity in mastocytoma P-815 cells by the cooperation of two prostaglandin E2 receptor subtypes, EP3 and EP4. J. Biol. Chem. 278: 17977-17981.
52. Weller, C. L., S. J. Collington, A. Hartnell, D. M. Conroy, T. Kaise, J. E. Barker, M. S. Wilson, G. W. Taylor, P. J. Jose, and T. J. Williams. 2007. Chemotactic action of prostaglandin E2 on mouse mast cells acting via the PGE2 receptor 3. Proc. Natl. Acad. Sci. USA 104: 11712-11717.